Chylopericardium Management

Diagnostic Features

The European Society of Cardiology recommends that pericardial fluid with a milky white, turbid, or opalescent appearance is diagnostic of chylopericardium 1, 2
Protein concentration in pericardial fluid ranges from 22-60 g/L, which is a key diagnostic feature 2
Fat droplets are visible microscopically with Sudan III staining, confirming the diagnosis of chylopericardium 2

The European Heart Society suggests that initial conservative therapy should combine dietary modification with pericardial drainage, reserving octreotide for cases that fail simple conservative measures 2, 3
A medium-chain triglyceride (MCT) diet, where MCTs comprise more than 20% of total energy intake, is recommended as part of dietary management 4, 5
Pericardiocentesis or pericardial tube drainage is necessary for symptom relief and to obtain fluid for analysis 2, 3

Octreotide, at a dose of 100 mcg subcutaneously three times daily for 2 weeks, may be considered if conservative management fails, based on a Class IIb recommendation from the European Society of Cardiology 1, 5
The mechanism of octreotide involves reducing chyle production by decreasing lymphatic flow 5

Surgical treatment, including thoracic duct ligation and resection, pericardio-peritoneal window, or thoracic duct embolization, is mandatory if conservative management and octreotide fail after 2 weeks, or if high-output drainage persists 2, 3, 4
The European Heart Society recommends thoracic duct ligation and resection as the most effective surgical option when the duct location is identified 2, 3

Prolonged conservative therapy beyond 2 weeks is not recommended, as it can lead to hypoalbuminemia, lymphocyte depletion, and increased mortality 4
Full anticoagulation should be avoided in iatrogenic pericardial effusion, as it increases the risk of tamponade 1, 6
Underlying causes of secondary chylopericardium, such as malignancy, infection, or thoracic duct obstruction, must be addressed 2, 3